Facebook Linkedin RSS Twitter Youtube
Home 2022

Healthcare financing

StockWatch: Analysts Sour on Roche after Alzheimer’s Clinical Failure
Cancer

StockWatch: Analysts Sour on Roche after Alzheimer’s Clinical Failure

SPAC Revival: AUM Pursues $400M Deal to Develop Cancer Pipeline
Cancer

SPAC Revival: AUM Pursues $400M Deal to Develop Cancer Pipeline

Form (Bio) Follows Function: Software Platform Targets Synbio
Drug Discovery

Form (Bio) Follows Function: Software Platform Targets Synbio

Cancer I-O Pioneer, Executive Target Immune Disruption with $65M Startup
Cancer

Cancer I-O Pioneer, Executive Target Immune Disruption with $65M Startup

IPO Raises $175M for Prime, Developer of “Search and Replace” Gene Editing Platform
Genome Editing

IPO Raises $175M for Prime, Developer of “Search and Replace” Gene Editing Platform

Biotechnology Gets $2 Billion Boost from the White House
Bioprocessing

Biotechnology Gets $2 Billion Boost from the White House

StockWatch: Investors Warm to Amylyx as FDA Panel Revisits ALS Drug
Cancer

StockWatch: Investors Warm to Amylyx as FDA Panel Revisits ALS Drug

Top 50 NIH-Funded Institutions of 2022
A-Lists

Top 50 NIH-Funded Institutions of 2022

Fewer Financings, Plunging Valuations May Stoke M&A Activity, EY Predicts
Industry News

Fewer Financings, Plunging Valuations May Stoke M&A Activity, EY Predicts

Into Orbit: Satellite Bio Raises $110M toward Tissue Therapeutics
GEN Edge

Into Orbit: Satellite Bio Raises $110M toward Tissue Therapeutics

1...345...21Page 4 of 21
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.